Attached files
file | filename |
---|---|
EX-10.1 - PROMISSORY NOTE DATED OCTOBER 19, 2016 - Echo Therapeutics, Inc. | ex10-1.htm |
UNITED STATES
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of
1934
Date of report (Date of earliest event reported): October 19,
2016
Echo Therapeutics, Inc.
(Exact name of Company as specified in its
charter)
Delaware
|
001-35218
|
41-1649949
|
(State
or other jurisdiction of
Incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer Identification
No.)
|
99
Wood Avenue South., Suite 302
Iselin,
NJ
|
|
08830
|
(Address
of principal executive offices)
|
|
(Zip
Code)
|
Company’s telephone number, including area code: (732)
201-4194
(Former name or former address, if changed since last
report)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the Company under
any of the following provisions (see General Instruction A.2.
below):
☐
|
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
☐
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
|
☐
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
|
Item
2.03 Creation of a Direct
Financial Obligation or an Obligation Under an Off- Balance Sheet
Arrangement of a Registrant.
On
October 19, 2016, Echo Therapeutics, Inc. (the
“Company”) issued a promissory note to Network Victory
Limited (“Lender”) in the aggregate principal amount of
$125,000 in respect of a bridge loan made by such party. The
promissory note, which bears interest at 18% per annum, may, at
Lender’s option, be exchanged for securities issued in a
subsequent financing by the Company.
The
description of the promissory note set forth herein does not
purport to be complete and is qualified in its entirety by
reference to the promissory note, a copy of which is attached
hereto as Exhibit 10.1 and incorporated herein by
reference.
Item 9.01 Financial Statements
and Exhibits.
10.1 Promissory
Note with Network Victory Limited dated October 19,
2016.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
Company has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
ECHO THERAPEUTICS, INC.
|
|
Dated:
October 19, 2016
|
By:
/s/ Alan W.
Schoenbart
|
|
|
Alan W.
Schoenbart
|
|
|
Chief
Financial Officer
|
|
|
|
Exhibit Index
10.1
Promissory Note with Network Victory Limited
dated October 19, 2016.